OLUMIANT (BARICITINIB) — FDA Approval NDA207924 (ELI LILLY AND CO)
OLUMIANT (BARICITINIB) — FDA Approval NDA207924 (ELI LILLY AND CO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OLUMIANT; Active ingredients: BARICITINIB; Application number: NDA207924.
| Brand name | OLUMIANT |
|---|---|
| Active ingredients | BARICITINIB |
| Application number | NDA207924 |
| Sponsor | ELI LILLY AND CO |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20180531 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →